...
首页> 外文期刊>Biomaterials >Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases
【24h】

Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases

机译:用于治疗神经变性疾病的反应性氧物种响应药物递送系统

获取原文
获取原文并翻译 | 示例

摘要

Neurodegenerative diseases and disorders seriously impact memory and cognition and can become life-threatening. Current medical techniques attempt to combat these detrimental effects mainly through the administration of neuromedicine. However, drug efficacy is limited by rapid dispersal of the drugs to off-target sites while the site of administration is prone to overdose. Many neuropathological conditions are accompanied by excessive reactive oxygen species (ROS) due to the inflammatory response. Accordingly, ROS-responsive drug delivery systems have emerged as a promising solution. To guide intelligent and comprehensive design of ROS-responsive drug delivery systems, this review article discusses the two following topics: (1) the biology of ROS in both healthy and diseased nervous systems and (2) recent developments in ROS-responsive, drug delivery system design. Overall, this review article would assist efforts to make better decisions about designing ROS-responsive, neural drug delivery systems, including the selection of ROS-responsive functional groups.
机译:神经变性疾病和疾病严重影响记忆和认知,可以成为危及生命的疾病。目前的医学技术试图通过神经医性的给药来解决这些不利影响。然而,药效受到药物的快速分散到偏离靶位点的限制,而施用部位易于过量。许多神经病理病症由于炎症反应而伴随过量的反应性氧物质(ROS)。因此,ROS响应药物输送系统已成为有希望的解决方案。为了引导ROS响应药物交付系统的智能和综合设计,本综述文章讨论了以下两个主题:(1)健康和患病神经系统的ROS生物学和(2)罗斯响应,药物交付的最新发展系统设计。总体而言,本综述文章将协助努力做出关于设计ROS响应性神经药物递送系统的更好决定,包括选择ROS响应官能团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号